AISLING CAPITAL MANAGEMENT LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | BBIO | 5.09M | $389.30M |
 | BMEA | 2.05M | $2.54M |
 | GLUE | 1.47M | $23.09M |
 | SNDX | 1.32M | $27.67M |
 | CMPS | 1.20M | $8.27M |
 | BCAX | 569K | $9.57M |
 | BBOT | 565K | $7.07M |
 | CALC | 521K | $3.43M |
 | ACRS | 434K | $1.31M |
 | MRKR | 325K | $484.80K |
 | URGN | 108K | $2.53M |
 | OKUR | 89K | $256.96K |
 | SRRK | 77K | $3.39M |
BridgeBio Pharma, Inc.
BBIO
Shares Held
5.09M
Value
$389.30M
Biomea Fusion, Inc.
BMEA
Shares Held
2.05M
Value
$2.54M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
1.47M
Value
$23.09M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.32M
Value
$27.67M
COMPASS Pathways plc
CMPS
Shares Held
1.20M
Value
$8.27M
Bicara Therapeutics Inc. Common Stock
BCAX
Shares Held
569K
Value
$9.57M
BridgeBio Oncology Therapeutics Inc.
BBOT
Shares Held
565K
Value
$7.07M
CalciMedica, Inc.
CALC
Shares Held
521K
Value
$3.43M
Aclaris Therapeutics, Inc.
ACRS
Shares Held
434K
Value
$1.31M
Marker Therapeutics, Inc.
MRKR
Shares Held
325K
Value
$484.80K
UroGen Pharma Ltd.
URGN
Shares Held
108K
Value
$2.53M
OnKure Therapeutics, Inc.
OKUR
Shares Held
89K
Value
$256.96K
Scholar Rock Holding Corporation
SRRK
Shares Held
77K
Value
$3.39M